May 3, 2024:

The Big Ten Cancer Research Consortium (Big Ten CRC) is excited to announce the release of a new public service announcement (PSA), showcasing the importance of scientific research collaboration among the Big Ten Cancer Centers. This PSA appears on the Big Ten Network.

The Big Ten CRC is united in transforming cancer research by leveraging the scientific and clinical expertise of each of the Big Ten universities to bring more cancer treatments and therapies to patients who need them.

“We are thrilled to partner with the Big Ten Cancer Research Consortium on its new PSA highlighting the innovative advancements in cancer treatment that have resulted from the collaborative efforts of the Big Ten Cancer Centers.” said Tony Petitti, Commissioner, Big Ten Conference.

Developed ten years ago, the Consortium was founded on the shared belief by Big Ten Cancer Centers that bringing together the brightest minds from across the member institutions would accelerate progress in cancer research and improve outcomes for patients across the Big Ten region and beyond.

“The Big Ten Conference is much more than outstanding athletics but also outstanding education and research,” said Howard Bailey, MD, director of the University of Wisconsin Carbone Cancer Center. “The Big Ten Cancer Research Consortium is a great example of this: 15 world-class cancer centers working together to advance our understanding and lessen the impact of cancer.”

The PSA was developed by the Big Ten Conference and the Big Ten Cancer Research Consortium. Tune into the Big Ten Network to see the PSA or view it here.

About the Big Ten Cancer Research Consortium: The Big Ten Cancer Research Consortium was created in 2013 to transform the conduct of cancer research through collaborative clinical trials and observational studies that seek to improve the lives of cancer patients in the diverse communities we serve by leveraging the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium creates a unique team research culture to drive science rapidly from ideas to treatment and prevention. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow. Since its founding, the Big Ten CRC has activated nearly 40 clinical trials across a wide range of cancer types, more than 1,000 participants have enrolled in Big Ten CRC studies, and more than 500 researchers have joined Big Ten CRC Clinical Trial Working Groups.

About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The broad-based programs of the 14 Big Ten institutions will provide over $200 million in direct financial support to more than 9,800 students for more than 11,000 participation opportunities on 350 teams in 42 different sports. The Big Ten sponsors 28 official conference sports, 14 for men and 14 for women, including the addition of men’s ice hockey and men’s and women’s lacrosse since 2013. For more information, visit www.bigten.org.